Placeholder Banner

BIO Congratulates Senate on Passage of GMO Disclosure Package

July 8, 2016

Washington, D.C. (July 8, 2016) – The Biotechnology Innovation Organization (BIO) congratulates the U.S. Senate for approving the bipartisan Roberts-Stabenow GMO labeling and disclosure solution and now urges passage by the U.S. House of Representatives.

 

“BIO applauds last night’s Senate vote to pass the GMO disclosure legislation,” said Jim Greenwood, BIO’s President and CEO. “We thank Senators Roberts and Stabenow for their leadership and congratulate them, along with other Senate and House leaders, on advancing this much-needed legislative remedy to the GMO disclosure issue.”

 

“But the work isn’t finished,” added Greenwood. “BIO urges the House of Representatives to take up and pass this bill without further modification next week so that it can be sent to President Obama for his signature before the Congress adjourns for the summer recess.” 

 

 

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Discover More
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…